Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Helix Ventures is a healthcare-focused venture capital firm based in Palo Alto, California. Founded in 2008 by Evgeny Zaytsev and Philip Sawyer, it specializes in investments in innovative therapeutic product opportunities that address significant patient needs and create value for investors. The firm is known for its hands-on approach with management teams and typically invests in early-stage drug and medical device companies but remains open to exceptional later-stage deals. Its investment focus excludes diagnostics, healthcare services, or IT firms. Portfolio highlights include iScience Interventional (ophthalmology), Invuity (medical devices), and Coherus Biosciences (biosimilars). The fund has participated alongside major VCs like Kleiner Perkins and Valence Life Sciences.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Helix Ventures.